Outcome for surgically staged localized prostate cancer treated with external beam radiation therapy

Journal of Urology

Volumn 157, Issue 5, 1997, Pages 1754-1759

  Powell, Curt R ^a   Huisman, Thomas K ^a   Riffenburgh, Robert H ^a   Saunders, Eric L ^a   Bethel, Kelly J ^a   Johnstone, Peter A S ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

neoplasm staging; prostatic neoplasms; radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030981921     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64854-7     Document Type: Article

References (21)

1. Barzell, W., Bean, M. A., Hilaris, B. S. and Whitmore, W. F., Jr.: Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J. Urol., 118: 278, 1977.
2. Donohue, R. E., Augspurger, R. R., Mani, J. H., Biber, R. J., Whitesel, J. A., Fauver, H. E., Mohr, S., Wettlaufer, J. N., Scanavino, D. and Pfister, R. R.: Pelvic lymph node dissection. Guide to patient management in clinically, locally confined adenocarcinoma of prostate. Urology, 20: 559, 1982.
3. Johnstone, P. A., Riffenburgh, R., Saunders, E. L. and Willison, F. W.: Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy. Int. J. Rad. Oncol. Biol. Phys., 32: 479, 1995.
4. Middleton, R. G., Thompson, I. M., Austenfeld, M. S., Cooner, W. H., Correa, R. J., Gibbons, R. P., Miller, H. C., Osterling, J. E., Resnick, M. I., Smalley, S. R. and Wasson, J. H.: Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J. Urol., 154: 2144, 1995.
5. Herr, H. W.: Pelvic lymphadenectomy and iodine-125 implantation. In: Genitourinary Tumors: Fundamental Principles and Surgical Techniques. Edited by D. E. Johnson and M. A. Boileau. New York: Grune & Stratton, chapt. 6, pp. 63-73, 1982.
6. Byar, D. P. and Mostofi, F. K.: Carcinoma of the prostate: prognostic evaluation of certain pathological features in 208 radical prostatectomies. Examined by the step-section technique. Cancer, 30: 5, 1972.
7. Gleason, D. F.: Classification of prostatic carcinomas. Cancer Chemother. Rep., 50: 125, 1966.
8. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observation. J. Amer. Stat. Ass., 53: 457, 1958.
9. Bagshaw, M. A., Cox, R. S. and Ray, G. R.: Status of radiation treatment of prostate cancer at Stanford University. Natl. Cancer Inst. Monogr., 7: 47, 1988.
10. Bagshaw, M. A., Cox, R. S. and Hancock, S. L.: Control of prostate cancer with radiotherapy: long-term results. J. Urol., 152: 1781, 1994.
11. Hanks, G. E., Perez, C. A., Kozar, M., Asbell, S. O., Pilepich, M. V. and Pajak, T. F.: PSA confirmation of cure at 10 years of T1b, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation. Int. J. Rad. Oncol. Biol. Phys., 30: 289, 1994.
12. Lee, R. J. and Sause, W. T.: Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy: fifteen-year results. Urology, 43: 640, 1994.
13. Hahn, P., Baral, E., Cheang, M., Kostrya, J. and Roelss, R.: Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987. Int. J. Rad. Oncol. Biol. Phys., 34: 41, 1996.
14. Kuban, D. A., el-Mahdi, A. M. and Schellhammer, P. F.: Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int. J. Rad. Oncol. Biol. Phys., 32: 307, 1995.
15. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
16. Middleton, R. G., Smith, J. A., Jr., Melzer, R. B. and Hamilton, P. E.: Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J. Urol., 136: 422, 1986.
17. Blute, M. L., Nativ, O., Zincke, H., Farrow, G. M., Therneau, T. and Lieber, M. M.: Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. J. Urol., 142: 1262, 1989.
18. Zincke, H., Bergstralh, E. J., Blute, M. L., Myers, R. P., Barrett, D. M., Lieber, M. M., Martin, S. K. and Oesterling, J. E.: Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J. Clin. Oncol., 12: 2254, 1994.
19. Hanks, G. E., Asbell, S., Krall, J. M., Perez, C. A., Doggett, S., Rubin, P., Sause, W. and Pilepich, M. V.: Outcome for lymph node dissection negative T-1b, T-2 (A-2, B) prostate cancer treated with external beam radiation therapy in RTOG 77-06. Int. J. Rad. Oncol. Biol. Phys., 21: 1099, 1991.
20. Zietman, A. L., Coen, J. J., Dallow, K. C. and Shipley, W. U.: The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int. J. Rad. Oncol. Biol. Phys., 32: 287, 1995.
21. Schellhammer, P. J., el-Mahdi, A. M., Wright, G. L., Jr., Kolm, P. and Ragle, R.: Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate. Urology, 42: 13, 1993.